You Searched For "Turing Pharmaceuticals" and got 20 results
Sort By:
Congressman: Shkreli claims to want to explain himself, now he'll get his chance
"I have been trying for the better part of a year to get information from Martin Shkreli about his …
Lydia Ramsey  Â
Here's what's happened to the companies Martin Shkreli used to run
Excerpts from documents obtained by Congress indicate that Shkreli expected the move to increase th…
Lydia Ramsey  Â
'He was born this way': Martin Shkreli's lawyer used Lady Gaga lyrics to defend his client
Shkreli's lawyer peppered his opening statement with Lady Gaga lyrics. "As Lady Gaga said, he was b…
Lydia Ramsey,Reuters  Â
Reviled pharma CEO Martin Shkreli is reportedly about to stop leading one of his companies
At Turing, which launched in February 2015, Shkreli acquired the US rights to Daraprim, a 62-year-o…
Lydia Ramsey  Â
Here's why Martin Shkreli says he still hasn't lowered the price of the critical drug he hiked from $13.50 to $750
Shkreli said his company, Turing Pharmaceuticals, wants to reevaluate is how much of a demand there…
Lydia Ramsey  Â
Martin Shkreli's old company has now completely imploded
In addition to executive departures and a delisting of shares, Marcum LLP resigned as KaloBios' ind…
Myles Udland  Â
We have a trial date for Martin Shkreli
He caught the country's attention, though, when the company he started after that, Turing, raised t…
Linette Lopez  Â
Martin Shkreli's former company had a $23,000 yacht party while claiming it was losing money
In addition, Chaffetz noted that a number of Turing employees received major raises while coming un…
Lydia Ramsey  Â
Congress just blasted Martin Shkreli
The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assi…
Lydia Ramsey  Â
Martin Shkreli's plan to charge $750-per-pill for Daraprim just suffered a big setback
Baum said this stocking price model is very different from the way Imprimis will operate. He called…
Lydia Ramsey  Â
Martin Shkreli is still refusing to answer to the US government for jacking up the price of a critical drug, and he's not alone
Already, Valeant, run by J. Michael Pearson, and Turing, run by Martin Shkreli, have rebuffed reque…
Lydia Ramsey  Â
Valeant is using the Martin Shkreli defense to explain away Hillary Clinton's attack on the company
After being made aware of this patient's story in January, we reached out to her to see if we could…
Linette Lopez  Â
Pharma CEO Martin Shkreli failed to respond to Bernie Sanders about his drug hike - and he's not happy
Sanders and co-author Sen. Elijah Cummings (D-MD) are investigating sudden hikes in the costs of ol…
Lydia Ramsey  Â
A pharma CEO just jacked up the price of a 62-year-old drug by $736 a pill, and he's responding to critics on Twitter with Eminem quotes
He also discussed his business strategy for rewarding scientists who develop new treatments for Tur…
Lydia Ramsey  Â
The company that raised the price of a drug by 5,000% posted a $14.6 million net loss for third quarter
By September, medical groups wrote a letter expressing their concern, and the news started getting …
Lydia Ramsey  Â
A 62-year-old drug just increased 55X in price - and now it's getting Hillary Clinton's attention
On September 8, medical groups Infectious Diseases Society of America (IDSA) and the HIV Medic…
Lydia Ramsey  Â
The former hedge funder who jacked up a drug's price by 5,000% has hired lobbyists
After news of the price hike broke, Democrats on the House Oversight and Government Reform Committe…
Lucinda Shen  Â
The Senate just released a massive report on drug pricing - here's what you need to know
The report also listed out policy solutions to price gouging instances like this, including incenti…
Lydia Ramsey  Â
Martin Shkreli is in prison - and could face a harsher punishment when he's sentenced for securities fraud next year
Shkreli, who gained notoriety in 2015 for hiking up the price of a life-saving AIDS drug, was convi…
Mark Abadi  Â
Martin Shkreli is out on $5 million bond
Shkreli, 32, was arrested on Thursday morning by federal authorities on charges of securities fraud…